Venous Thromboembolic Event Rates Up With ChAdOx1-S Vaccine

WEDNESDAY, May 19, 2021 -- The rates of venous thromboembolic events, including cerebral venous thrombosis, are increased among recipients of the Oxford-AstraZeneca vaccine ChAdOx1-S, although the absolute rates are small, according to a study...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news